Buy Dr Reddys Labs, target of Rs 581: Angel

Published on Thu, Jan 22, 2009 at 12:37 |  Source : Moneycontrol.com

Updated at Thu, Jan 22, 2009 at 12:40  

19612 Investors following Dr Reddys Labs. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Angel Broking has maintained its buy rating on Dr Reddys Laboratories with a target price of Rs 581 in its January 21, 2009 research report. "For 3QFY2009, DRL registered a yoy growth in Net Sales of 50.5% to Rs 1,805 crore (Rs 1,199 crore). On the valuation front, the stock is trading at 15.6x FY2009E and 13.8x FY2010E EPS. We maintain our Buy on the stock, with a target price of Rs 581," says Angel's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......

  

Trending News

Business News

Sony to roll-out ICS update next week, Xperia PLAY gets the boot
Why are states so reluctant to cut petrol taxes? "Why are states so reluctant to cut petrol taxes?"

Kolkata Knight Riders win maiden IPL title

UBS India Says On CNBC-TV18 Strong Visibility Lends Comfort To FMCG Valuations

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 27 2012, 11:52 | Source: CNBC-TV18

Expect to maintain EBIDTA margin ahead: Wockhardt  

May 27 2012, 11:00 | Source: CNBC-TV18

e-commerce market in India: What's in store?  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!